Avalo Therapeutics (AVTX) EBIT Margin Growth (5y) (2021 - 2025)
Avalo Therapeutics (AVTX) EBIT Margin Growth (5y) (2021 - 2025) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
| 10 |
Avalo Therapeutics |
295.77 Mn |
295.77 Mn |
- |
| Date | Value |
|---|
| Dec 31, 2025 |
-3.24 Mn |
| Dec 31, 2024 |
-594,749.00 |
| Sep 30, 2024 |
-503,506.00 |
| Dec 31, 2023 |
-136,583.00 |
| Sep 30, 2023 |
-99,231.00 |
| Jun 30, 2023 |
-99,176.00 |
| Mar 31, 2023 |
-176,720.00 |
| Dec 31, 2022 |
-76,028.00 |
| Sep 30, 2022 |
-6,016.00 |
| Jun 30, 2022 |
-2,018.00 |
| Mar 31, 2022 |
-128,345.00 |
| Dec 31, 2021 |
-727,572.00 |
| Sep 30, 2021 |
63,537.00 |
| Jun 30, 2021 |
2,567.00 |
